NR3C2 and congestive heart failure: Before the start of chemotherapy, ACE inhibitor, beta-blocker, mineralocorticoid receptor antagonist (MRA), sodium-glucose cotransporter-2 (SGLT2) inhibitor, and oral anticoagulant were administered in line with the chronic heart failure (CHF) protocol.